VIR Q3 2020 8-K ER

Company

Vir Biotechnology, Inc.

Filed

November 10, 2020

Period of Report

November 10, 2020

Accession Number

0001564590-20-052954

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →